On ECHEMI
Home > Drugs > Metformin hydrochloride Registered Holders
Metformin hydrochloride structure

Metformin hydrochloride structure

Metformin hydrochloride

Metformin (hydrochloride) is an FDA approved first-line drug for the treatment of type 2 diabetes. Metformin decreases hepatic glucose production, mostly through a mild and transient inhibition of the mitochondrial respiratory-chain complex 1.

Find 58 Related Holders

WOCKHARDT LTD
Brazil Brazil

API Registration Country

API Inactive
  • Country:

    Brazil Brazil
  • Address:

    WOCKHARDT TOWERS, BANDRA KURLA COMPLEX, EXTERIOR - EX
  • Email:

OLON S.P.A.
European Union European Union

API Registration Country

API Inactive
THINQ PHARMA-CRO LIMITED
European Union European Union

API Registration Country

API Inactive
SUN PHARMACEUTICAL INDUSTRIES LIMITED
European Union European Union

API Registration Country

API Inactive
BLUE CIRCLE ORGANICS PRIVATE LIMITED
European Union European Union

API Registration Country

API Inactive
Aastrid International Private Limited
European Union European Union

API Registration Country

API Inactive
Smruthi Organics Limited
European Union European Union

API Registration Country

API Inactive
KORES (INDIA) LIMITED
European Union European Union

API Registration Country

API Inactive
AARTI DRUGS LIMITED
European Union European Union

API Registration Country

API Inactive
AMRI INDIA PRIVATE LIMITED
European Union European Union

API Registration Country

API Inactive
Recommended Suppliers of Metformin hydrochloride
View 136 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.